Health Professional Radio - Podcast

Meredith Manning, President of the Americas at PharmaEssentia , a global biotech, discusses the company’s work utilizing the power of interferons, a naturally occurring substance that helps the body’s immune system fight infection and diseases. PharmaEssentia has pioneered technology that leverages pegylation (or “extended release”) to administer interferons in a tolerable and effective way to tre...

Dr. Tahamtan (Tahi) Ahmadi, M.D., Ph. D., Executive Vice President & Chief Medical Officer, Head of Experimental Medicines at Genmab, an international biotechnology company, discusses the announcement from Genmab and Abbvie that the U.S. Food and Drug Administration (FDA) has accepted for priority review the Biologics License Application for epcoritamab (DuoBody ®-CD3xCD20), an investigational...

Mike Knox, father and author of the book "Vivien's Rain: My Daughter's Battle with Epilepsy" shares his journey with his daughter who was diagnosed with epilepsy when she was two and is now 16, and talks about Vivien's success with VNS Therapy™. His recent efforts have been focused on passing a law for police and law enforcement in California to be trained on seizures and seizure first aid with th...

Returning guest, actor-producer, comic book author, and father, Greg Grunberg shares his personal journey as a caregiver and advocate to his own son, Jake who is living with epilepsy and he talks about how he is hosting an inspirational online video series called "The Care Giver" where he travels across the county helping tell stories of others in the epilepsy community…providing them strength kno...

Dr. Bob Dagher, MD, Chief Medical Officer at Enveric Biosciences , a biotechnology company dedicated to developing novel small-molecule therapeutics to transform the treatment of anxiety, depression, and addiction disorders discusses the company's lead candidate, a next-generation, psilocybin analogue (psychedelics), that has been rationally designed to optimize delivery, offer dosing flexibility,...

Andreas Raptopoulos, founder and CEO of Matternet, the first drone-centric healthcare delivery organization to secure Type Certification and a Production Certificate from the Federal Aviation Administration, discusses how he and his team are utilizing safety-focused and environmentally-sensitive best practices to actively transform deliveries conducted between hospitals, laboratories, pharmacies a...

Dr. George W. Sledge, Jr., newly appointed Executive Vice President and Chief Medical Officer of Caris Life Sciences , discusses why he made the move to Caris and the groundbreaking work he’ll be leading. #CarisLifeSciences Dr. George W. Sledge, Jr. joined Caris Life Sciences in October 2022 and serves as Executive Vice President and Chief Medical Officer. In this role, Dr. Sledge has oversight fo...

Dr. Corey Cutler, MD, MPH, FRCPC, Medical Director, Stem Cell Transplant Program, Dana-Farber Cancer Institute and Vice President, American Society for Transplantation and Cellular Therapy (ASTCT) and GVHD patient Meredith A. Cowden, MA, AT, LPCC-S, Patient Advocacy Director of the Meredith A. Cowden Foundation discuss graft-versus-host-disease (GVHD), a rare disease that commonly impacts allogene...

Dr. Ryan Case, PhD, Head of Clinical Medical Affairs at Neuroderm , a Mitsubishi Tanabe Pharma Corporation (MTPC), discusses the highly positive results from the pivotal Phase III BouNDless trial evaluating ND0612 in Parkinson’s disease patients with motor fluctuations. ND0612 is a drug-device combination therapy – a 24 hours/day, continuous subcutaneous infusion of liquid levodopa/carbidopa (LD/C...

Lisa Yañez, CEO of Aerami Therapeutics , a clinical-stage biopharmaceutical company dedicated to breathing life into the treatment of serious cardiopulmonary conditions, discusses the company's plans to advance AER-901, a drug-device combination comprised of imatinib for inhalation and the FOX ® nebulizer into a Phase 2 trial in 2023. She talks about the approach to clinical development in pulmona...

Returning guest, Dr. Rick Baehner, MD, Chief Medical Officer of Precision Oncology at Exact Sciences discusses new data presented at the 2022 San Antonio Breast Cancer Symposium (SABCS) that strengthen the value of the Oncotype DX ® Breast Recurrence Score test as well as other data supporting their precision portfolio. He talks about Exact Science's role in helping breast cancer patients make inf...

Dr. Rakesh Suri, President and Chief Medical Officer at Fountain Life , a preventative health and longevity company discusses Fountain Life's unique data-driven approach that enables finding illnesses, including cancer, cardiac, metabolic, and neurodegenerative disease, early before they can cause harm. The company has three open U.S. sites in Naples, FL, Dallas, TX, and White Plains, NY. Dr. Suri...

Dr. Jeff Gudin, MD, Sr. Medical Advisor, Drug Monitoring and Toxicology at Quest Diagnostics discusses a report that he co-authored that found that one in two patients (49%) showed signs of prescription drug misuse in 2021 including use of amphetamines (stimulants, such as Adderall) which surged 5-fold over the last decade. He shares his views on avenues out of the drug crisis and talks about the...

Returning guest, Dr. Derek Wallace, MBBS, Vice President and Global Dengue Program Head at Takeda discusses the dengue program and the European Commission (EC) approval of the company’s dengue vaccine, QDENGA ® (TAK-003) , for the prevention of dengue disease caused by any serotype in individuals from four years of age in the European Union (EU). #Takeda #QDENGA #Dengue Derek Wallace, MBBS, is Vic...

Dr. Holly Johnson, Director of Medical Information at Myriad Mental Health discusses the GeneSight test that analyzes genes to see how a person may respond to commonly prescribed mental health medications. She also talks about a recent survey looking at the relationship between primary care physicians and their patients when it comes to mental health issues. #GeneSight Holly Johnson is the Directo...

Graft-versus-host disease, also known as GVHD, is a life-threatening condition that can occur after an allogeneic stem cell transplant, or the transfer of stem cells from a donor, where the donated cells initiate an immune response and attack the transplant recipient’s organs, leading to significant morbidity and mortality. To help support those living with GVHD, Incyte created the Incyte Ingenuit...

Dr. Antonio Anzueto, Professor of Medicine and Section Chief of Pulmonary at South Texas Veterans Healthcare System, an affiliated Institution with the University of Texas Health San Antonio, discusses the 2023 Global Obstruction Lung Disease (GOLD)  Report that recommends long-acting muscarinic antagonist (LAMA), long-acting beta agonist (LABA), or LAMA+LABA therapy  as a first-line tre...

Sangamo Therapeutics is working to translate groundbreaking science into genomic cures. Jason Fontenot, Senior Vice President and Chief Scientific Officer of Sangamo, discusses cutting-edge science on the frontiers of genomic medicine, and promising treatments for genomic diseases once thought to be intractable. #genomicmedicine #genetherapy #celltherapy Jason Fontenot, Ph. D., serves as Sangamo’s...

Dr. Robert Risinger, Chief Medical Officer, Neuroscience at BioXcel Therapeutics , a biopharmaceutical company that uses artificial intelligence (AI) to identify drug targets and develop drugs in neuroscience and immuno-oncology, discusses the company's lead product, IGALMI™ (dexmedetomidine), a sublingual film used to treat agitation associated with schizophrenia or bipolar disorder and three mor...

Jamie McCoy, General Manager of Theranostics and Radiotherapeutics at GE HealthCare discusses theranostics and how it is changing the treatment of prostate cancer and what impact this will have on patients. #GEHealthCare James (Jamie) H. McCoy is the Global General Manager for GE HealthCare’s theranostics segment. In this role he is creating the company-wide theranostics strategy, connecting and c...

Dr. Allison McMullen, PhD, Scientific Partner for Molecular Diagnostics at Roche Diagnostics discusses a survey that shows that many Americans are confused by the differences between PCR tests and rapid antigen tests and when to use them. She talks about the importance of early diagnosis to differentiate between similar-looking respiratory viruses (including flu, COVID, and RSV), the available tes...

Prof. Arik Eisenkraft, MD., VP Clinical & Regulation at Biobeat , a digital tech company developing its proprietary data collection tools for remote patient monitoring (RPM), discusses the company’s wrist monitor and the chest monitor, both FDA-cleared to monitor stroke volume and cardiac output in addition to its previous clearances in monitoring cuffless blood pressure, blood oxygen saturati...

David Harrell, Chairman and CEO of TranspareRX, the leading healthcare technology company bringing transparency to prescription drug pricing discusses Cuverd ™ (pronounced 'covered') a new website and app that guides patients to get the lowest prescription cost possible. #Cuverd David Harrell is the Chairman and CEO of TranspareRx, the leading healthcare technology company bringing transparency to...

Cardiologists at Northwestern Medicine are using AI to identify patients with advanced heart failure who require specialized care, including those who might need ventricular assistance devices or transplant.​ Dr. Faraz Ahmad, MD, MS, cardiologist and associate director of Northwestern Medicine Bluhm Cardiovascular Institute’s Center for Artificial Intelligence discusses heart failure, how AI is gi...

Dr. Deborah Young, director of the Division of Behavioral Research for the Kaiser Permanente Southern California Department of Research & Evaluation discusses the findings of a study published by the "American Journal of Preventive Medicine," which found that increased levels of physical activity are associated with less severe COVID-19 outcomes regardless of risk factors such as excess weight...